Form D · Pharmaceuticals

Curative Biotechnology Inc

Boca Raton, FL · CIK 0001400271

Offering snapshot reported Jan 18, 2023 · SEC filing

Reported sold
$146K
Offering amount: $919K
Investors reported
11
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Dec 15, 2022
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Jan 18, 2023Initial$146,000No comparison11SEC filing
Mar 21, 2022Initial$1,000,000No comparison1SEC filing
Oct 13, 2009Initial$247,500No comparison1SEC filing
Apr 23, 2008PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-470987

Sales compensation recipients

Scroll to see all columns →

RecipientCRDAssociated broker-dealer
NoneNone

Source: Form D, filed Jan 18, 2023. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Michael Fish Director
I Richard Garr Executive
Barry A. Ginsberg Director, Executive
Paul Michaels Director, Executive
Garr Richard Executive
Ronn Schuman Director, Executive
Cary Sucoff Director
Lawrence Zaslow Director

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
1825 Nw Corporate Blvd Suite 110
Boca Raton, FL, 33431